Hearing Loss Trial, Recruiting NCT03707691 Sponsor: Hospices Civils de Lyon Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT03707691
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For adults:

  • People between 18 and 90 years old
  • People who do not have any neurological or psychiatric conditions
  • People who do not have significant cognitive difficulties and are able to understand and follow the study instructions
  • People who are motivated to take part actively in the study
  • People who are willing to sign a written consent form agreeing to participate
  • People who are covered by social security
  • For a specific part of the study (Experiment 5), people who are compatible with MRI and MEG scanning equipment (confirm with trial site)

For children and young people:

  • Children aged 5 years and older
  • Children whose parents or legal guardians have given written consent for them to participate
  • Children with no history of neurological or psychiatric conditions
  • Children without significant cognitive difficulties who are able to understand and follow the study instructions
  • Children who are covered by social security
  • Children who are motivated to take part actively in the study

Who may not be able to join:

For adults:

  • People younger than 18 or older than 90
  • Women who are pregnant or breastfeeding

For children and young people:

  • Minors who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anne CACLIN, Hospices Civils de Lyon

Phone: 4 72 13 89 04

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 November 2019
Est. completion
26 October 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

percentages of correct responses in listening tests; reaction times in listening tests; Event-Related Fields; Oscillations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov